company background image
BELL logo

Belluscura AIM:BELL Stock Report

Last Price


Market Cap







19 Feb, 2024


Company Financials +

BELL Stock Overview

Belluscura plc develops and commercialize oxygen related medical device products.

BELL fundamental analysis
Snowflake Score
Future Growth5/6
Past Performance0/6
Financial Health3/6

Belluscura plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Belluscura
Historical stock prices
Current Share PriceUK£0.26
52 Week HighUK£0.52
52 Week LowUK£0.15
1 Month Change45.71%
3 Month Change4.08%
1 Year Change-40.70%
3 Year Changen/a
5 Year Changen/a
Change since IPO-51.89%

Recent News & Updates

Recent updates

Here's Why We're A Bit Worried About Belluscura's (LON:BELL) Cash Burn Situation

Dec 22
Here's Why We're A Bit Worried About Belluscura's (LON:BELL) Cash Burn Situation

Shareholder Returns

BELLGB Medical EquipmentGB Market

Return vs Industry: BELL underperformed the UK Medical Equipment industry which returned -2.2% over the past year.

Return vs Market: BELL underperformed the UK Market which returned -5.4% over the past year.

Price Volatility

Is BELL's price volatile compared to industry and market?
BELL volatility
BELL Average Weekly Movement10.7%
Medical Equipment Industry Average Movement8.1%
Market Average Movement4.9%
10% most volatile stocks in GB Market11.2%
10% least volatile stocks in GB Market2.5%

Stable Share Price: BELL's share price has been volatile over the past 3 months.

Volatility Over Time: BELL's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of UK stocks.

About the Company

201524Bob Rauker

Belluscura plc develops and commercialize oxygen related medical device products. The company offers X-PLOR, a modular portable oxygen concentrator. Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.

Belluscura plc Fundamentals Summary

How do Belluscura's earnings and revenue compare to its market cap?
BELL fundamental statistics
Market capUK£35.07m
Earnings (TTM)-UK£7.94m
Revenue (TTM)UK£954.60k


P/S Ratio


P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BELL income statement (TTM)
Cost of RevenueUS$314.50k
Gross ProfitUS$888.06k
Other ExpensesUS$10.89m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date


Earnings per share (EPS)-0.073
Gross Margin73.85%
Net Profit Margin-831.70%
Debt/Equity Ratio0.4%

How did BELL perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.